Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 0 | 0 | 146 | 6,389 | 6,861 |
| Gross Profit | N/A | N/A | 146 | 6,389 | 6,861 |
| Operating Expenses | 80,361 | 57,858 | 54,052 | 59,882 | 172,168 |
| Operating Income | -80,361 | -57,858 | -53,906 | -53,493 | -165,307 |
| Other Income | 385 | -59,938 | 789 | -830 | 10 |
| Pre-tax Income | -79,976 | -117,796 | -53,117 | -54,323 | -165,297 |
| Net Income Continuous | -79,976 | -117,796 | -53,117 | -54,323 | -165,297 |
| Net Income | $-79,976 | $-117,796 | $-53,117 | $-54,323 | $-165,297 |
| EPS Basic Total Ops | -56.97 | -104.95 | 143.93 | -79.46 | -197.90 |
| EPS Basic Continuous Ops | -57.20 | -105.15 | -55.49 | -59.47 | -190.06 |
| EPS Diluted Total Ops | -56.97 | -104.95 | 143.93 | -79.46 | -197.90 |
| EPS Diluted Continuous Ops | -57.20 | -105.15 | -55.41 | -59.47 | -190.06 |
| EPS Diluted Before Non-Recurring Items | -56.97 | -50.98 | N/A | N/A | N/A |
| EBITDA(a) | $-79,233 | $-57,229 | $-53,331 | $-53,124 | $-165,017 |